FMS

NYSE Fresenius Medical Care AG Sponsored ADR
Nov 11, 2026 · 5:30 AM ET LAST TRADE Market Closed

$22.85 ↑ +0.11 (+0.48%) Trading Up from the previous close of $22.74

YTD change
-4.07%
vs 20-day SMA
+1.69%
vs 200-day SMA
-0.26%

Price ranges

Previous day
$22.53 $23.00
open $23.00 close $22.74
-$0.26 (-1.13%)
Today
$0.00 $0.00
$22.85
Past week
$21.73 $23.83
from $21.73 now $22.85
+$1.12 (+5.15%)
Past month
$20.91 $23.83
from $21.08 now $22.85
+$1.77 (+8.40%)
This year
$20.02 $26.42
from $23.82 now $22.85
-$0.97 (-4.07%)

Price & Performance

+0.98 (+4.50%) / 6M

$20.14$22.13$24.12$26.11May 11Aug 11Nov 10

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 60.6% away from all-time highs of $57.94
  • FMS is down 4% since the beginning of the year
  • FMS is down 5% over the past 12 months
  • FMS is up 8% over the past 1 month
  • 1% of all FMS investors are betting against FMS
  • Number of investors short FMS has gone up 40% versus last month

FMS reads neutral: price sits above one of the two key moving averages, short interest is rising month over month, the 12-month move is -5.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.621295
Earnings momentum -11.1% Quarterly EPS growth
Quarterly change -11.1%

Valuation

P/E ratio 6.19
Enterprise value $24.3B
Beta 0.44

Balance sheet & scale

Income$946.6K
Revenue$22.5B
Cash$1.2B
Debt$12.4M
Income / Debt 0.08×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE
Sector Health Care and Social Assistance
Sub Sector Ambulatory Health Care Services
Market cap $11.9B

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Competitor comparison

TickerCompany PriceChange
FMCQF Fresenius Medical Care AG $47.84 N/A
DVA DaVita Inc. $179.28 -3.37%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.